Litigation Details for Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2021)
✉ Email this page to a colleague
Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-11-12 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,092,541; 6,962,940; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amgen Inc. v. Sandoz Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Biologic Drugs cited in Amgen Inc. v. Sandoz Inc.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-01-30 | 27 | ’541 patent U.S. Patent No. 10,092,541 (Appx10619-10640) ’638 patent U.S. Patent No. 7,…, U.S. Patent No. 8,455,536 (the ` 536 Patent"), U.S. Patent No. 10,092,541 (the "' 541…claims 2, 19, and 21 of U.S. Patent No. 10,092,541 (the "' 541 Patent") ( … States Patent (10) Patent No.: US 10,092,541 B2 …0013 Certified Copy of U.S. Patent No. 10,092,541 ....................... Appx10619 Case: | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
